Differential intracellular signaling through PAC1 isoforms as a result of alternative splicing in the first extracellular domain and the third intracellular loop

Molecular Pharmacology

Volumn 72, Issue 1, 2007, Pages 103-111

  Ushiyama, Mina ^a   Ikeda, Ryuji ^a   Sugawara, Hideki ^a   Yoshida, Morikatsu ^b   Mori, Kenji ^b   Kangawa, Kenji ^b   Inoue, Kazuhiko ^a   Yamada, Katsushi ^a   Miyata, Atsuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; MESSENGER RNA; PROTEIN SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CALCIUM CELL LEVEL; CELL LINE; CYTOPLASM; DNA FLANKING REGION; HUMAN; HUMAN CELL; LIGAND BINDING; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; RECEPTOR AFFINITY; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

ALTERNATIVE SPLICING; ANIMALS; CALCIUM; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIC AMP; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; POLYMERASE CHAIN REACTION; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I; RNA, MESSENGER; SIGNAL TRANSDUCTION; VASOACTIVE INTESTINAL PEPTIDE;

EID: 34347207562     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.035477     Document Type: Article

References (32)

1. Aino H, Hashimoto H, Ogawa N, Nishino A, Yamamoto K, Nogi H, Nagata S, and Baba A (1995) Structure of the gene encoding the mouse pituitary adenylate cyclase-activating polypeptide receptor. Gene 164:301-304.
2. Alexandre D, Vaudry H, Grumolato L, Turquier V, Fournier A, Jegou S, and Anouar Y (2002) Novel splice variants of type I pituitary adenylate cyclase-activating polypeptide receptor in frog exhibit altered adenylate cyclase stimulation and differential relative abundance. Endocrinology 143:2680-2692.
3. Cao YJ, Gimpl G, and Fahrenholz F (1995) The amino-terminal fragment of the adenylate cyclase activating polypeptide (PACAP) receptor functions as a high affinity PACAP binding domain. Biochem Biophys Res Commun 212:673-680.
4. Daniel PB, Kieffer TJ, Leech CA, and Habener JF (2001) Novel alternatively spliced exon in the extracellular ligand-binding domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) type 1 receptor (PAC1R) selectively increases ligand affinity and alters signal transduction coupling during spermatogenesis. J Biol Chem 276:12938-12944.
5. Dautzenberg FM, Mevenkamp G, Wille S, and Hauger RL (1999) N-terminal splice variants of the type I PACAP receptor: isolation, characterization and ligand binding/selectivity determinants. J Neuroendocrinol 11:941-949.
6. Gottschall PE, Tatsuno I, Miyata A, and Arimura A (1990) Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide. Endocrinology 127:272-277.
7. Harmar AJ (2001) Family-B G-protein-coupled receptors. Genome Biol 2:REVIEWS3013.10.
8. Hasegawa H, Negishi M, and Ichikawa A (1996) Two isoforms of the prostaglandin E receptor EP3 subtype different in agonist-independent constitutive activity. J Biol Chem 271:1857-1860.
9. Hashimoto H, Ishihara T, Shigemoto R, Mori K, and Nagata S (1993) Molecular cloning and tissue distribution of a receptor for pituitary adenylate cyclase-activating polypeptide. Neuron 11:333-342.
10. Hosoya M, Onda H, Ogi K, Masuda Y, Miyamoto Y, Ohtaki T, Okazaki H, Arimura A, and Fujino M (1993) Molecular cloning and functional expression of rat cDNAs encoding the receptor for pituitary adenylate cyclase activating polypeptide (PACAP). Biochem Biophys Res Commun 194:133-143.
11. Ishihara T, Shigemoto R, Mori K, Takahashi K, and Nagata S (1992) Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 8:811-889.
12. Koch T, Schulz S, Pfeiffer M, Klutzny M, Schroder H, Kahl E, and Hollt V (2001) C-terminal splice variants of the mouse mu-opioid receptor differ in morphine-induced internalization and receptor resensitization. J Biol Chem 276:31408-31414.
13. Lerner EA, Ribeiro JM, Nelson RJ, and Lerner MR (1991) Isolation of maxadilan, a potent vasodilatory peptide from the salivary glands of the sand fly Lutzomyia longipalpis. J Biol Chem 266:11234-11236.
14. Lutz EM, Ronaldson E, Shaw P, Johnson MS, Holland PJ, and Mitchell R (2006) Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP. Mol Cell Neurosci 31:193-209.
15. Lutz EM, Shen S, Mackay M, West K, and Harmar AJ (1999) Structure of the human VIPR2 gene for vasoactive intestinal peptide receptortype 2. FEBS Lett 458:197-203.
16. Lutz EM, Sheward WJ, West KM, Morrow JA, Fink G, and Harmar AJ (1993) The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett 334:3-8.
17. Mammi C, Frajese GV, Vespasiani G, Mariani S, Gnessi L, Farini D, Fabbri A, Frajese G, and Moretti C (2006) PAC1-R null isoform expression in human prostate cancer tissue. Prostate 66:514-521.
18. 2+ flux assays for high-throughput screening. J Biomol Screen 10:780-787.
19. Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L, Culler MD, and Coy DH (1989) Isolation of a novel 38 residue-hypothalamic polypeptide which stimulatesadenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164:567-574.
20. Miyata A, Jiang L, Dahl RD, Kitada C, Kubo K, Fujino M, Minamino N, and Arimura A (1990) Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun 170:643-648.
21. Mori K, Miyazato M, Ida T, Murakami N, Serino R, Ueta Y, Kojima M, and Kangawa K (2005) Identification of neuromedin S and its possible role in the mammalian circadian oscillator system. EMBO J 24:325-335.
22. Moro O, and Lerner EA (1997) Maxadilan, the vasodilator from sand flies, is a specific pituitary adenylate cyclase activating peptide type I receptor agonist. J Biol Chem 272:966-970.
23. Moro O, Wakita K, Ohnuma M, Denda S, Lerner EA, and Tajima M (1999) Functional characterization of structural alterations in the sequence of the vasodilatory peptide maxadilan yields a pituitary adenylate cyclase-activating peptide type 1 receptor-specific antagonist. J Biol Chem 274:23103-28110.
24. Morrow JA, Lutz EM, West KM, Fink G, and Harmar AJ (1993), Molecular cloning and expression of a cDNA encoding a receptor for pituitary adenylate cyclase activating polypeptide (PACAP). FEBS Lett 329:99-105.
25. Pan YX (2005) Diversity and complexity of the mu opioid receptor gene: alternative pre-mRNA splicing and promoters. DNA Cell Biol 24:736-750.
26. Pantaloni C, Brabet P, Bilanges B, Dumuis A, Houssami S, Spengler D, Bockaert J, and Journot L (1996) Alternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation. J Biol Chem 271:22146-22151.
27. Pisegna JR, and Wank SA (1993) Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor. Proc Natl Acad Sci U S A 90:6345-6349.
28. Pisegna JR, and Wank SA (1996) Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase activating polypeptide receptor. Evidence for dual coupling to adenylate cyclase and phospholipase C. J Biol Chem 271:17267-17274.
29. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg PH, and Journot L (1993) Differential signal transduction by five splice variants of the PACAP receptor. Nature 365:170-175.
30. Suzuki R, Arata S, Nakajo S, Ikenaka K, Kikuyama S, and Shioda S (2003) Expression of the receptor for pituitary adenylate cyclase-activatin polypeptide (PAC1-R) in reactive astrocytes. Brain Res Mol Brain Res 115:10-20.
31. Tatsuno I, Gottschall PE, Koves K, and Arimura A (1990) Demonstration of specific binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) in rat astrocytes. Biochem Biophys Res Commun 168:1027-1033.
32. Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, and Vaudry H (2000) Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev 52:269-324.